Age and Early Graft Function Relate With Risk-Benefit Ratio of Allogenic Islet Transplantation Under Antithymocyte Globulin-Mycophenolate Mofetil-Tacrolimus Immune Suppression: Erratum
- PMID: 29190258
- DOI: 10.1097/TP.0000000000001971
Age and Early Graft Function Relate With Risk-Benefit Ratio of Allogenic Islet Transplantation Under Antithymocyte Globulin-Mycophenolate Mofetil-Tacrolimus Immune Suppression: Erratum
Erratum for
-
Age and Early Graft Function Relate With Risk-Benefit Ratio of Allogenic Islet Transplantation Under Antithymocyte Globulin-Mycophenolate Mofetil-Tacrolimus Immune Suppression.Transplantation. 2017 Sep;101(9):2218-2227. doi: 10.1097/TP.0000000000001543. Transplantation. 2017. PMID: 27779572
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
